Abstract
Using a general equilibrium heterogeneous agent model featuring health production, we quantify the contribution of health price in explaining cross-country differences in health expenditures and health status. Considering other country-specific explanatory factors, US health prices are estimated to be 33% higher than those of European countries. This price differential explains more than 60% of the difference in health expenditures and more than half of the difference in health status between Europe and the United States. Despite its large impact at the aggregate level, these price differences increase the lifetime cost of living of Americans by 2 percentage points.
Publication
Journal of Political Economy 131, no. 8 (2023): 1949-1993.
Related
- Le travail indépendant passé 50 ans : le rôle de la richesse individuelle et des coûts de création d'entreprise (2007). Économie et Statistique, number 403-404.
- Entrepreneurship, Wealth, Liquidity Constraints, and Start-Up Costs (2007). Comparative Labor Law & Policy Journal, 28(4).
- Accounting for the Rise of Health Spending and Longevity (2021). Journal of European Economic Association. Vol. 19, Issue 1, February: 536-579.
- Early Impact of the COVID-19 Pandemic on Household Finances in Québec (2020). Canadian Public Policy/Analyse de politiques, Vol. 46, Issue S3, pages S217-S235. October.
- The Effect of Education on Health: Evidence from National Compulsory Schooling Reforms (2020). Spanish Economics Review. SERIEs, 11, pages 83-103.